{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:26:40Z","timestamp":1792715200418,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ygyno.2016.10.031","type":"journal-article","created":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T14:00:26Z","timestamp":1477576826000},"page":"51-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":130,"title":["Triaging HPV-positive women with p16\/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial"],"prefix":"10.1016","volume":"144","author":[{"suffix":"Jr.","given":"Thomas C.","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Ranger-Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Rehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Stoler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruediger","family":"Ridder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2016.10.031_bb0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ygyno.2015.01.538","article-title":"Transitioning to a new era in cervical cancer screening","volume":"136","author":"Schiffman","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2016.10.031_bb0010","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jcv.2015.11.015","article-title":"Triage of HPV positive women in cervical cancer screening","volume":"76","author":"Wentzensen","year":"2016","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.ygyno.2016.10.031_bb0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.10.031_bb0020","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ygyno.2014.12.022","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"136","author":"Huh","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.10.031_bb0025","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/AOG.0b013e3182883a34","article-title":"2012 ASCCP Consensus Guidelines Conference. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"121","author":"Massad","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2016.10.031_bb0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ygyno.2011.02.033","article-title":"Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16\/Ki-67 dual-stained cytology","volume":"121","author":"Petry","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2016.10.031_bb0035","doi-asserted-by":"crossref","first-page":"djv257","DOI":"10.1093\/jnci\/djv257","article-title":"p16\/Ki-67 dual stain cytology for detection of cervical precancer in HPV-positive women","volume":"107","author":"Wentzensen","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2016.10.031_bb0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1155\/2007\/678793","article-title":"Biomarkers in cervical cancer screening","volume":"23","author":"Wentzensen","year":"2007","journal-title":"Dis. Markers"},{"key":"10.1016\/j.ygyno.2016.10.031_bb0045","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/cncy.21473","article-title":"Interobserver reproducibility and accuracy of p16\/Ki-67 dual-stain cytology in cervical cancer screening","volume":"122","author":"Wentzensen","year":"2014","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.ygyno.2016.10.031_bb0050","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/jnci\/djt235","article-title":"Screening for cervical cancer precursors with p16\/Ki-67 dual-stained cytology: results of the PALMS study","volume":"105","author":"Ikenberg","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2016.10.031_bb0055","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/cncy.20140","article-title":"p16\/ki-67 dual-stain cytology in the triage of ASCUS and LSIL Papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study","volume":"119","author":"Schmidt","year":"2011","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.ygyno.2016.10.031_bb0060","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-12-0270","article-title":"Performance of p16\/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population","volume":"18","author":"Wentzensen","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2016.10.031_bb0065","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ygyno.2012.05.004","article-title":"p16\/Ki-67 dual staining in cervico-vaginal cytology: correlation with histology, human papillomavirus detection and genotyping in women undergoing colposcopy","volume":"126","author":"Don\u00e0","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.10.031_bb0070","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/cncy.21205","article-title":"p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities","volume":"120","author":"Roelens","year":"2012","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.ygyno.2016.10.031_bb0075","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1038\/bjc.2014.34","article-title":"Triaging borderline\/mild dyskaryotic Pap cytology with p16\/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study","volume":"110","author":"Uijterwaal","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.10.031_bb0080","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/cncy.21542","article-title":"Prospective evaluation of p16\/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results","volume":"123","author":"Bergeron","year":"2015","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.ygyno.2016.10.031_bb0085","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1002\/ijc.29290","article-title":"Triaging HPV-positive women with normal cytology by p16\/Ki-67 dual-stained cytology testing: baseline and longitudinal data","volume":"136","author":"Uijterwaal","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.10.031_bb0090","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/cncy.21511","article-title":"Interpretation of p16(INK4a)\/Ki-67 dual immunostaining for the triage of human papillomavirus-positive women by experts and nonexperts in cervical cytology","volume":"123","author":"Allia","year":"2015","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.ygyno.2016.10.031_bb0095","first-page":"185","article-title":"A population of 1136 HPV DNA-HR positive women: expression of p16(INK4a)\/Ki67 dual-stain cytology and cytological diagnosis. Histological correlations and cytological follow up","volume":"107","author":"Rossi","year":"2015","journal-title":"Pathologica"},{"key":"10.1016\/j.ygyno.2016.10.031_bb0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/ajcp\/aqv019","article-title":"Use of cytology, E6\/E7 mRNA, and p16INK4a-Ki-67 to define the management of human papillomavirus (HPV)-positive women in cervical cancer screening","volume":"145","author":"Gustinucci","year":"2016","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2016.10.031_bb0105","doi-asserted-by":"crossref","first-page":"46.e1","DOI":"10.1016\/j.ajog.2011.07.024","article-title":"The ATHENA human papillomavirus study: design, methods, and baseline results","volume":"206","author":"Wright","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2016.10.031_bb0110","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1309\/AJCPTUS5EXAS6DKZ","article-title":"Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results","volume":"136","author":"Wright","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2016.10.031_bb0115","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2016.10.031_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2012.11.020","article-title":"Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16\/18: results from the ATHENA HPV study","volume":"208","author":"Cox","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2016.10.031_bb0125","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda system. Terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2016.10.031_bb0130","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/ajcp\/aqw125","article-title":"Knowledge of patients' human papillomavirus status at the time of cytologic review significantly affects the performance of cervical cytology in the ATHENA study","volume":"146","author":"Wright","year":"2016","journal-title":"Am. J. Clin. Pathol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816315086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816315086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T02:53:21Z","timestamp":1536288801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825816315086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0090825816315086"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.10.031","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triaging HPV-positive women with p16\/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}